2018

1. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

   The Lancet Oncology, Vol. 19, Núm. 11, pp. 1530-1542